相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis
Akira Tokumura et al.
International Journal of Medical Sciences (2012)
Characterization of non-lipid autotaxin inhibitors
Adrienne B. Hoeglund et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
(S)-M720-Vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity
William J. Valentine et al.
CELLULAR SIGNALLING (2010)
Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells
Susanne Vidot et al.
CELLULAR SIGNALLING (2010)
ATX expression and LPA signalling are vital for the development of the nervous system
Stella Fotopoulou et al.
DEVELOPMENTAL BIOLOGY (2010)
Development of an LC-MS/MS assay to determine plasma pharmacokinetics of the radioprotectant octadecyl thiophosphate (OTP) in monkeys
Hari Kosanam et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Optimization of a Pipemidic Acid Autotaxin Inhibitor
Adrienne B. Hoeglund et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery and Optimization of Boronic Acid Based Inhibitors of Autotaxin
Harald M. H. G. Albers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Pharmacophore Development and Application Toward the Identification of Novel, Small-Molecule Autotaxin Inhibitors
E. Jeffrey North et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
Molly K. Altman et al.
MOLECULAR CANCER (2010)
Autotaxin expression and its connection with the TNF-alpha-NF-κB axis in human hepatocellular carcinoma
Jian-Min Wu et al.
MOLECULAR CANCER (2010)
Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation
Harald M. H. G. Albers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation
James Gierse et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs
E. Jeffrey North et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases
Shuying Liu et al.
CANCER CELL (2009)
Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells
Silvia Jansen et al.
CANCER LETTERS (2009)
Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo
Honglu Zhang et al.
CANCER RESEARCH (2009)
Expression of Autotaxin and Acylglycerol kinase in prostate cancer: Association with cancer development and progression
Mohammed Ahmed Abdel Muneem Nouh et al.
CANCER SCIENCE (2009)
Unique Ligand Selectivity of the GPR92/LPA5 Lysophosphatidate Receptor Indicates Role in Human Platelet Activation
Jesica R. Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lysophosphatidic Acid 2 Receptor-mediated Supramolecular Complex Formation Regulates Its Antiapoptotic Effect
Shuyu E et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of Autotaxin Production or Activity Blocks Lysophosphatidylcholine-Induced Migration of Human Breast Cancer and Melanoma Cells
Cristoforo G. Gaetano et al.
MOLECULAR CARCINOGENESIS (2009)
Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis
N. Samadi et al.
ONCOGENE (2009)
Autotaxin Inhibition: Challenges and Progress Toward Novel Anti-Cancer Agents
Abby L. Parrill et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Lysophospholipid interactions with protein targets
Abby L. Parrill
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma
Akiko Masuda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
GPR87 is an overexpressed G-protein coupled receptor in squamous cell carcinoma of the lung
Mathias Gugger et al.
DISEASE MARKERS (2008)
S32826, A Nanomolar Inhibitor of Autotaxin: Discovery, Synthesis and Applications as a Pharmacological Tool
Gilles Ferry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Synthesis, pharmacology, and cell biology of sn-2-aminooxy analogues of lysophosphatidic acid
Joanna Gajewiak et al.
ORGANIC LETTERS (2008)
Alkoxymethylenephosphonate analogues of (Lyso)phosphatidic acid stimulate signaling networks coupled to the LPA2 receptor
Joanna Gajewiak et al.
CHEMMEDCHEM (2007)
Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity
Naoko Watanabe et al.
LIFE SCIENCES (2007)
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C
Naoko Watanabe et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2007)
α-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA
Guowei Jiang et al.
CHEMMEDCHEM (2007)
Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid
Ayako Uchiyama et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Cyclic phosphatidic acid is produced by autotaxin in blood
Satomi Tsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid
Masayuki Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis
Daniel L. Baker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development
Laurens A. van Meeteren et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours
I Dimova et al.
EUROPEAN JOURNAL OF CANCER (2006)
Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity
J Wu et al.
BIOCHEMICAL JOURNAL (2006)
Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands
GG Durgam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers
AA Jazaeri et al.
CLINICAL CANCER RESEARCH (2005)
Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARγ, and inhibitors of autotaxin
GG Durgam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family
H Sakagami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate
LA van Meeteren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression, regulation and function of autotaxin in thyroid carcinomas
A Kehlen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family
RD Duan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
A Tokumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
M Umezu-Goto et al.
JOURNAL OF CELL BIOLOGY (2002)
Plasma lysophosphatidic acid concentration and ovarian cancer
DL Baker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors
YC Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway
M Mukai et al.
FEBS LETTERS (2000)